Scientist Solutions - Pharmacokinetics


bottom of page		Forum Feed

Topic

Starter

Replies

Views

Last Post

Not
New

In Vivo PK

Merryl

1843

By ramesh padodara
Jul 29, 2008, 23:57 PM

Not
New

Bioequivalence

Chintan Patel

560

By ramesh padodara
Jul 22, 2008, 4:56 AM

Not
New

Drug Dissolution Testing

Qureshi

1711

By Qureshi
Jul 08, 2008, 21:59 PM

Not
New

Pharmacokinetics - Workshop for Beginners

Tony Rook

423

By Tony Rook
Oct 22, 2007, 14:32 PM

Not
New

Ibuprofen's inhibition of COX
» How does ibuprofen inhibit COX?

SME

1421

By montgomj
Feb 16, 2007, 18:45 PM

Not
New

Improving data reliability....
» non-compliance vs PK criteria

trook

484

By trook
Feb 15, 2007, 14:18 PM

Not
New

piclamilast

r.etges

1708

By vanishing
May 07, 2005, 18:54 PM

Not
New

Automatic Blood Samplers (autosamplers)

Merryl

1044

By Merryl
Jan 07, 2005, 0:18 AM

Not
New

CACO2

tbc

2299

By tbc
Jan 06, 2005, 19:41 PM

Not
New

Cassette Dosing

Merryl

1172

By Merryl
Nov 03, 2004, 23:49 PM

top of page
Forum Jump

New	New Hot	Pinned	Moved	Question	Caution Alert	Information
Not New	Not New Hot	Locked	Poll	Idea	Key Discovery	Answered Question
The dot ( ) shows that you have posted in the topic

Recent Related Publications
Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats. Lu Y A J Wang G Hao H Huang Q Yan B Zha W Gu S Ren H Zhang Y Fan X Zhang M Hao K Metabonomics is a systematic approach to the study of in vivo metabolic ... Rapid Commun Mass Spectrom. 2008 Aug 21;22(18):2882-2888. - Full Text - Pubmed
Screening and characterization of reactive metabolites using glutathione ethyl ester in combination with Q-trap mass spectrometry. Wen B Fitch WL The present study describes a new analytical approach for the detection ... J Mass Spectrom. 2008 Aug 21. - Full Text - Pubmed
Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question. Deeken JF Slack R Marshall JL Pharmacogenetic research indicates a relationship between a polymorphism ... Cancer. 2008 Aug 20. - Full Text - Pubmed
Strategies to prevent N-acetyltransferase-mediated metabolism in a series of piperazine-containing pyrazalopyrimidine compounds. Rawal J FAU - Jones, R Jones R FAU - Payne, A Payne A FAU - Gardner, I Gardner I 1. ... Xenobiotica. 2008 Sep;38(9):1219-39. - Full Text - Pubmed
Synthesis, Acoustic Stability, and Pharmacologic Activities of Papaverine-Loaded Echogenic Liposomes for Ultrasound Controlled Drug Delivery. Kee PH Abruzzo TA Smith DA Kopechek JA Wang B Huang SL Macdonald RC Holland CK McPherson DD Background: development of encapsulated therapeutics that could be ... J Liposome Res. 2008 Aug 21:1-15. - Full Text - Pubmed

Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats.

Screening and characterization of reactive metabolites using glutathione ethyl ester in combination with Q-trap mass spectrometry.

Irinotecan and uridine diphosphate glucuronosyltransferase 1A1 pharmacogenetics: to test or not to test, that is the question.

Strategies to prevent N-acetyltransferase-mediated metabolism in a series of piperazine-containing pyrazalopyrimidine compounds.

Synthesis, Acoustic Stability, and Pharmacologic Activities of Papaverine-Loaded Echogenic Liposomes for Ultrasound Controlled Drug Delivery.